Evaluating the User Performance and Experience with a Re-Engineered 4 mm × 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles

Skin and subcutaneous tissue thickness at insulin injection sites in Chinese diabetes patients: Clinical implications

(2016) W. Wang et al.   DIABETES & METABOLISM

Patient Reported Outcomes (PROs) used in recent Phase 3 trials for Type 2 Diabetes: A review of concepts assessed by these PROs and factors to consider when choosing a PRO for future trials

(2016) Matthew Reaney et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

New Insulin Delivery Recommendations

(2016) Anders H. Frid et al.   MAYO CLINIC PROCEEDINGS

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

(2016) William Polonsky et al.   Patient Preference and Adherence

Safety and Efficacy of Insulin Therapy Delivered via a 4mm Pen Needle in Obese Patients With Diabetes

(2015) Richard M. Bergenstal et al.   MAYO CLINIC PROCEEDINGS

Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study

(2014) M. Valentini et al.   CURRENT MEDICAL RESEARCH AND OPINION

Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection

(2012) Donatella Lo Presti et al.   PEDIATRIC DIABETES

Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations

(2010) Michael A. Gibney et al.   CURRENT MEDICAL RESEARCH AND OPINION